HCPCS code J7601 — Ensifentrine inh 3 mg. Status: Active. Effective Jan 1, 2025. Source: CMS HCPCS Level II.

J7601

Active

Ensifentrine inh 3 mg

Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2025
Code type: alphanumeric
OPPS Status: B — Code not recognized by OPPS — billed via another route

MUE — Medically Unlikely Edits

Maximum units of J7601 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Practitioner Services 2

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
83034-0003-60 Ohtuvayre

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q1
    Ensifentrine inh 3 mg